Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum.
作者信息
Farmer Isabel, Okikiolu Jumoke, Steel Matthew, Wanniarachchi Chandima, Littlewood Shona, Gupta Sunil, Thanigaikumar Muragaiyan, Oram S Helen, Moonim Mufaddal, Kulasekararaj Austin G, Yeghen Tullie
机构信息
Department of Haematology, Lewisham and Greenwich NHS Trust, London, UK.
Department of Histopathology, Guys and St Thomas NHS Foundation Trust, London, UK.
出版信息
Br J Haematol. 2020 Aug;190(4):e248-e250. doi: 10.1111/bjh.16864. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum.隐匿于新冠病毒疾病表象之下的急性早幼粒细胞白血病——诊断与治疗难题
Br J Haematol. 2020 Aug;190(4):e248-e250. doi: 10.1111/bjh.16864. Epub 2020 Jun 8.
2
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.口服砷剂联合维甲酸与静脉用砷剂联合维甲酸治疗非高危急性早幼粒细胞白血病的非劣效性、随机、3 期临床试验。
Lancet Oncol. 2018 Jul;19(7):871-879. doi: 10.1016/S1470-2045(18)30295-X. Epub 2018 Jun 5.
3
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning.急性早幼粒细胞白血病诊断时年龄较小与较好的长期认知功能相关。
Br J Haematol. 2020 Sep;190(5):e304-e307. doi: 10.1111/bjh.16877. Epub 2020 Jun 18.
4
Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France.法国儿童急性早幼粒细胞白血病对三氧化二砷联合全反式维甲酸的耐受性
Br J Haematol. 2020 Jan;188(1):170-173. doi: 10.1111/bjh.16364. Epub 2019 Dec 6.
5
Early detection of differentiation syndrome by chest ultrasound in acute promyelocytic leukaemia.急性早幼粒细胞白血病中通过胸部超声早期检测分化综合征
Br J Haematol. 2019 Feb;184(4):672-673. doi: 10.1111/bjh.15153. Epub 2018 Apr 1.
6
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.三氧化二砷与全反式维甲酸联合治疗儿童急性早幼粒细胞白血病
Br J Haematol. 2019 Apr;185(2):360-363. doi: 10.1111/bjh.15507. Epub 2018 Jul 20.
7
[Acute promyelocytic leukaemia].[急性早幼粒细胞白血病]
Ugeskr Laeger. 2018 Jan 15;180(3).
8
Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.全反式维甲酸和三氧化二砷成功治疗一名患有唐氏综合征和急性早幼粒细胞白血病的儿童。
J Pediatr Hematol Oncol. 2020 May;42(4):322-325. doi: 10.1097/MPH.0000000000001438.
9
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.三氧化二砷在治疗新诊断的急性早幼粒细胞白血病中是必需的。法国-比利时-瑞士 APL 组对一项随机试验（APL2006）的分析。
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
10
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.全反式维甲酸和三氧化二砷治疗非高危急性早幼粒细胞白血病的长期结果：APL0406意大利-德国随机试验的更新
Leukemia. 2020 Mar;34(3):914-918. doi: 10.1038/s41375-019-0589-3. Epub 2019 Oct 14.
引用本文的文献
1
COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: A lesson from Northern India.新冠病毒病（COVID-19）在合并罕见基础疾病患者中的病例及转归：来自印度北部的经验教训
Clin Epidemiol Glob Health. 2022 May-Jun;15:101044. doi: 10.1016/j.cegh.2022.101044. Epub 2022 Apr 12.
2
Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection.急性新冠病毒感染背景下急性早幼粒细胞白血病的管理
Leuk Res Rep. 2022 Oct 19;18:100353. doi: 10.1016/j.lrr.2022.100353. eCollection 2022.
3
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19.延迟诊断与多酪氨酸激酶抑制剂不耐受：1例慢性粒细胞白血病合并新型冠状病毒肺炎病例报告
Front Oncol. 2022 Jun 8;12:921587. doi: 10.3389/fonc.2022.921587. eCollection 2022.
4
Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.COVID-19 合并血液系统恶性肿瘤患者的合并症和死亡率：系统评价和荟萃分析。
J Clin Lab Anal. 2022 May;36(5):e24387. doi: 10.1002/jcla.24387. Epub 2022 Apr 6.
5
Weathering the storm: COVID-19 infection in patients with hematological malignancies.安然度过风暴：血液系统恶性肿瘤患者的 COVID-19 感染。
J Zhejiang Univ Sci B. 2020;21(12):921-939. doi: 10.1631/jzus.B2000423.
6
Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs?发展中国家的浆细胞骨髓瘤治疗：是否每个人都需要最新的药物？
Acta Haematol. 2020;143(6):513-515. doi: 10.1159/000505991. Epub 2020 Mar 10.
本文引用的文献
1
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
2
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
3
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
4
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
5
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.急性早幼粒细胞白血病的治疗：欧洲白血病网专家小组的最新建议。
Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25.
6
Mechanisms and management of coagulopathy in acute promyelocytic leukemia.急性早幼粒细胞白血病凝血异常的机制与处理。
Thromb Res. 2018 Apr;164 Suppl 1:S82-S88. doi: 10.1016/j.thromres.2018.01.041.
7
Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.早幼粒细胞白血病中的分化综合征：临床表现、发病机制与治疗。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011048. doi: 10.4084/MJHID.2011.048. Epub 2011 Oct 24.
8
The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.急性早幼粒细胞白血病凝血异常的发病机制与处理。
Br J Haematol. 2012 Jan;156(1):24-36. doi: 10.1111/j.1365-2141.2011.08922.x. Epub 2011 Nov 3.
9
Retinoic acid syndrome in acute promyelocytic leukemia.急性早幼粒细胞白血病中的维甲酸综合征。
Wis Med J. 1997 Apr;96(4):35-8.
Zotero 插件